PITTSBURGH & LONDON--(BUSINESS WIRE)--Helomics™ Corporation, a privately-held personalized healthcare company that provides comprehensive tumor profiling utilizing proprietary live cell and fixed cell products and services, announced today that it will be launching, in April, the 4th generation of the company’s comprehensive tumor profiling offering to include their “Precision Cellular Analytical Platform™” or PCAP™. The PCAP system will be used to further enhance Helomics’ research, industry a
| < Prev | Next > |
|---|
